COPD (chronic obstructive pulmonary disease) clinical trials
Medical name: Chronic obstructive pulmonary disease · Lungs & breathing
675 trials are recruiting, according to ClinicalTrials.gov.
Showing 100 of 675, newest first. Checked against the registry on 22 November 2026. Listing a trial here is not a recommendation; taking part is voluntary and each study team decides who is eligible.
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
Ages 40 Years to 80 Years · 246 sites · AstraZeneca
Details and how to check if you qualify · NCT06878261 on ClinicalTrials.gov
Developing an Intervention to Optimize Virtual Care Adoption for COPD Management
Ages 40 Years to no maximum · 2 sites · VA Office of Research and Development
Remote Intervention Versus Routine Monitoring in COPD Patients With Chronic Hypercapnia Receiving Home Non-invasive Respiratory Support
Ages 40 Years to 80 Years · 4 sites · Sir Run Run Shaw Hospital
RSV Vaccination to Reduce Recurrent AECOPD
Ages 50 Years to no maximum · 1 site · Chinese University of Hong Kong
cfMSC Stem Cell Therapy Targeting COPD
Ages 40 Years to 80 Years · 1 site · Shenzhen Geno-Immune Medical Institute
The AIRWARD Study: A Study to Test Whether Verducatib Helps People With Chronic Obstructive Pulmonary Disease
Ages 40 Years to no maximum · 26 sites · Boehringer Ingelheim
An Open-Label Extension Study to Evaluate Inhaled Treprostinil SMI in Participants With Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease (PH-COPD)
Ages 18 Years to no maximum · 15 sites · United Therapeutics
Investigating Senolytic Properties in Pulmonary Rehabilitation and Metformin in COPD Exacerbations
Ages 65 Years to no maximum · 1 site · Duke University
Comparative Effectiveness of Roflumilast and Azithromycin in Reducing Exacerbations in Severe Chronic Obstructive Pulmonary Disease ( COPD ) Patients With Chronic Bronchitis Phenotype
Ages 40 Years to no maximum · 0 sites · Sidra Aziz
Study of Fluticasone/Formoterol/Glycopyrronium for the Treatment Chronic Obstructive Pulmonary Disease (TRIPLAR)
Ages 40 Years to no maximum · 1 site · Eurofarma Laboratorios S.A.
Repeat Treatment With Metered Cryospray in Patients With Chronic Obstructive Pulmonary Disease With Chronic Bronchitis
Ages No minimum to 80 Years · 0 sites · CSA Medical, Inc.
Utility of Respiratory Biomarker Guidance in Exacerbations
Ages 18 Years to no maximum · 1 site · Université de Sherbrooke
A Study of the Effect of a Nurse Navigator Program on High Risk Patients
Ages 18 Years to no maximum · 1 site · Mayo Clinic
Sustainable Inhaler Prescribing in Intermediate Care Units
Ages 18 Years to no maximum · 1 site · Consorci Sanitari de l'Alt Penedès i Garraf
Pulmonary Rehabilitation Frequency in COPD Patients
Ages No minimum to no maximum · 0 sites · Hospital Universitario Fundación Alcorcón
Pulmonary Rehabilitation in African Countries
Ages 18 Years to no maximum · 3 sites · University of Edinburgh
Construction and Validation of a Clinical Cohort on the Pathogenesis Evolution and Syndrome-Differentiated Treatment of Chronic Obstructive Pulmonary Disease Based on Core Targets of Airway Inflammation and Remodeling
Ages 40 Years to no maximum · 4 sites · First Affiliated Hospital of Ningbo University
The Effect of Inhaled Nitric Oxide on Pulmonary Gas-exchange in COPD
Ages 18 Years to 85 Years · 0 sites · University of Alberta
Assessment of Upper Airway Patency
Ages 18 Years to no maximum · 1 site · Fisher and Paykel Healthcare
Portable Positive Pressure Therapy Device
Ages 21 Years to 85 Years · 0 sites · Koronis Biomedical Technologies
Effect on Bronchodilation Response and Ventilation Heterogeneity of Different Inhalation Volumes in COPD
Ages 40 Years to no maximum · 1 site · University of Milan
Effect of add-on Doxofylline on Lung Function in Stable COPD
Ages 40 Years to no maximum · 1 site · University of Milan
Effectiveness and Efficiency of Home Telemonitoring and Non-invasive Ventilation in Patients With COPD and Hypercapnia (EVALECO)
Ages 50 Years to 90 Years · 1 site · Air Liquide Healthcare Spain
Performance of Lumetry for Arterial Carbon Dioxide (paCO2) Assessment and Chronic Obstructive Pulmonary Disease (COPD) Screening
Ages 18 Years to 90 Years · 1 site · Lumetry Diagnostics GmbH
Reducing Exposure With Air Cleaners and Technology
Ages 13 Years to no maximum · 3 sites · University of California, Berkeley
The Aim of the Study is to Decipher the Alterations in Signalling Pathways of Skeletal Muscle Stem Cells (Satellite Cells (SCs)) in Individuals With COPD, as Well as to Examine the Effect of Exercise Training on SCs.
Ages 18 Years to 75 Years · 3 sites · University Hospital, Bordeaux
Digital Inhaler Use in Obstructive Lung Disease Care
Ages 18 Years to no maximum · 1 site · Cedars-Sinai Medical Center
High-Intensity Interval Alternating Concentric-Eccentric Training in Chronic Respiratory Disease
Ages 18 Years to no maximum · 1 site · Fu Jen Catholic University Hospital
Ensifentrine (MK-5884) Study for the Prevention of Chronic Obstructive Pulmonary Disease (COPD) Exacerbations in Adults With a History of Moderate or Severe Exacerbations While Receiving Standard of Care (SOC) (MK-5884-031/RPL554/ENHANCE-3)
Ages 40 Years to 80 Years · 7 sites · Merck Sharp & Dohme LLC
Home-based Pulmonary Rehabilitation for COPD Patients
Ages 40 Years to 100 Years · 1 site · Karolinska Institutet
Effectiveness of Active Cycle of Breathing Techniques in Patients With Chronic Obstructive Pulmonary Disease
Ages 40 Years to 90 Years · 1 site · National Yang Ming Chiao Tung University Hospital
Validation of 1 Minute Sit-to Stand Test for Assessment of Breathlessness at Exertion in Individuals With Chronic Lung Disease
Ages 18 Years to no maximum · 1 site · Jacob Sandberg
EFFECT OF COMBINED VIRTUAL REALITY-GUIDED BREATHING AND AEROBIC TRAINING ON VENTILATORY FUNCTION IN PATIENTS WITH COPD
Ages 45 Years to 55 Years · 0 sites · Cairo University
Phase 2b Efficacy and Safety Study of AERO-007, an Inhaled LABA+LAMA Combination for Nebulization Delivery in COPD Patients
Ages 40 Years to 75 Years · 2 sites · AeroRx Therapeutics Inc.
Study of Treprostinil Administered Via Soft Mist Inhaler (SMI) in Participants With Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease (PH-COPD)
Ages 18 Years to no maximum · 16 sites · United Therapeutics
Chronic Respiratory Disease Participant Engagement Study
Ages 18 Years to no maximum · 1 site · Richmond Research Institute
Acute Muscular and Vascular Responses to a Single Session of Exercise With BFR in COPD
Ages 45 Years to no maximum · 1 site · University Hospital, Grenoble
A Study of RSS0343 Tablets in Healthy Participants and in Participants With Mild or Moderate Renal Impairment
Ages 18 Years to 65 Years · 1 site · Reistone Biopharma Company Limited
Effect of Dietary Fiber Supplementation on Systemic Inflammation and Clinical Parameters in COPD
Ages 18 Years to 75 Years · 1 site · Júnea Regina Pires Drews
Multimodal Assessment of Neuromuscular Electrical Stimulation (NMES) Effects on Respiratory and Peripheral Muscles in Chronic Obstructive Pulmonary Disease (COPD)
Ages 40 Years to no maximum · 1 site · Universitas Padjadjaran
Impact of Multidisciplinary Care, Structured and Targeted on the COPD Patient's Clinical Pathway.
Ages 18 Years to no maximum · 1 site · Centre Hospitalier Universitaire de Nīmes
COINCIDE: Cardineurovascular dIsease and Obstructive Airway Disease
Ages 18 Years to no maximum · 0 sites · VASCage GmbH
Urolithin A Supplementation During Pulmonary Rehabilitation in Patients With COPD
Ages 40 Years to no maximum · 0 sites · Bryan A. Ross
A Study to Assess the Efficacy and Safety of Co-administration of GSK3862995B With GSK5784283 in Adult Participants With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
Ages 40 Years to 80 Years · 10 sites · GlaxoSmithKline
Firefighter's Longitudinal Airway and Respiratory Exposome/Multiome Study (FLARES)
Ages 18 Years to 65 Years · 1 site · National Institute of Allergy and Infectious Diseases (NIAID)
Feasibility of Noninvasive Trigeminal Nerve Stimulation During Exercise
Ages 18 Years to 75 Years · 1 site · Johns Hopkins University
A Study of RO7830698 in Healthy Participants and Participants With Chronic Obstructive Pulmonary Disease
Ages 18 Years to 80 Years · 1 site · Hoffmann-La Roche
Evaluating Customized Antibiotic Duration (CDA) Strategy in Acute Exacerbations of COPD
Ages 18 Years to 90 Years · 1 site · Capital Development Authority (CDA)
A Study to Investigate the Efficacy and Safety of Zelicapavir Compared With Placebo in Adults With RSV Who Are at High Risk for Severe Disease
Ages 18 Years to no maximum · 4 sites · Enanta Pharmaceuticals, Inc
RESP-FIT: A Respiratory Muscle Strength Training Intervention for COPD
Ages 40 Years to no maximum · 0 sites · Medical University of South Carolina
Long-term Effects and Maintenance of Exercise Habits in Individuals With COPD
Ages 40 Years to 80 Years · 1 site · Copenhagen University Hospital, Rigshospitalet
Impact of Nurse-Led Pulmonary Rehabilitation on Dyspnea, Fatigue and Self-Efficacy in COPD Patients
Ages 40 Years to no maximum · 0 sites · University of Health Sciences Lahore
Combinaison of Virtual Reality and Rehabilitation to Improve Muscle Function, Exercise Tolerance, Exertional Symptoms and Dyspnea in Patients With Chronic Respiratory Disease: a Randomized Cross-over Trial
Ages 18 Years to no maximum · 1 site · Fondation Hôpital Saint-Joseph
A Continuation Study of Tilrekimig in Adults With Moderate-to-Severe Long-Term Breathing Difficulty, Known by the Medical Term of Chronic Obstructive Pulmonary Disease (COPD) to Learn About This Medicine When Used for a Long Period of Time
Ages 35 Years to 80 Years · 3 sites · Pfizer
THERMotherapy Against Persistent Bacterial LUNG Infections
Ages 18 Years to no maximum · 1 site · Chronic Obstructive Pulmonary Disease Trial Network, Denmark
Indoor Overheating and Physiological Strain in Older Adults With COPD
Ages 60 Years to 80 Years · 1 site · University of Ottawa
Investigation of the Effect of Structured Energy Conservation Techniques Training on COPD Patients
Ages 40 Years to no maximum · 1 site · Akdeniz University
Effect of Video Game-Based Breathing Exercises on Respiratory Dysfunction in ACOS
Ages 40 Years to 74 Years · 1 site · Istinye University
This After Market Study is Seeing if Dupilumab Plus Usual Standard of Care (SOC) is Better Than Usual Care Alone for Adult Participants After a Severe Chronic Obstructive Pulmonary Disease (COPD) Flare-Up Requiring Hospitalization
Ages 40 Years to no maximum · 1 site · Regeneron Pharmaceuticals
Effects of TPB-Based Cadence Exercise and Breathing Training on Physiological Parameters and Quality of Life in Patients With COPD
Ages 40 Years to no maximum · 2 sites · Fu Jen Catholic University Hospital
Multi-Omics Study of COPD Stages and Traditional Chinese Medicine Syndromes
Ages 35 Years to no maximum · 0 sites · Guangzhou Institute of Respiratory Disease
The Impact of Indoor Environmental Quality on Symptoms in Patients With Chronic Obstructive Pulmonary Disease
Ages 18 Years to no maximum · 1 site · Ziekenhuis Oost-Limburg
Improving Medication Management in COPD
Ages 45 Years to no maximum · 0 sites · Duke University
Airway Dysfunction, Occlusions and Remodeling: COPD Patients and Mepolizumab
Ages 55 Years to 85 Years · 0 sites · Western University, Canada
Upper Airway Morphology and Physiology During Graded Positive Pressure and Nasal High Flow: An MRI Study
Ages 18 Years to no maximum · 1 site · Klinikum Dortmund Wirbelsäulenchirurgie
A Study to Investigate Small Mobile Stem Cells (SMS) in Moderate to Severe Chronic Obstructive Pulmonary Disease
Ages 18 Years to no maximum · 1 site · SMSbiotech
PBMT Associated With a Pulmonary Rehabilitation Program on the Functional Capacity of Patients With COPD
Ages 18 Years to 90 Years · 1 site · Federal University of Health Science of Porto Alegre
Primary Palliative Care - a Feasibility Cluster Trial
Ages 18 Years to no maximum · 1 site · University of Coimbra
Nutritional Risk and Diaphragmatic Thickness in Mechanically Ventilated COPD Patients
Ages 60 Years to no maximum · 0 sites · Assiut University
Effectiveness of Pollution Monitoring in Clinical Exercise Rehabilitation
Ages 18 Years to no maximum · 1 site · University of Leicester
A Clinical Study of REGEND001 for the Treatment of Chronic Obstructive Pulmonary Disease (COPD)
Ages 40 Years to 75 Years · 1 site · Regend Therapeutics
RESET-COPD Cohort: Real-Time Monitoring and Early Warning in COPD Patients Receiving Home NPPV
Ages 18 Years to no maximum · 1 site · Beijing Chao Yang Hospital
Comparison of Arterial and Capillary Blood Gas Analyses in Patients With Respiratory Distress Due to COPD or APE
Ages 18 Years to no maximum · 1 site · Centre Hospitalier Universitaire de Nice
The CANadian EXAcerbation of COPD Trial
Ages 40 Years to no maximum · 1 site · McGill University Health Centre/Research Institute of the McGill University Health Centre
BREZTRI REGULATORY POST MARKETING SURVEILLANCE IN KOREA
Ages No minimum to no maximum · 10 sites · AstraZeneca
A Study to Evaluate the Long-term Safety and Efficacy of Lunsekimig in Adult Participants With Chronic Obstructive Pulmonary Disease (COPD)
Ages 40 Years to 80 Years · 16 sites · Sanofi
A Study to Understand the Accuracy of a New Breathing Device Compared to Standard Testing for Asthma and COPD
Ages 18 Years to 110 Years · 1 site · Liverpool Heart and Chest Hospital NHS Foundation Trust
A Study to Investigate the Efficacy and Safety of GSK5784283 (Felcorekibart) Compared With Placebo in Participants With Moderate to Very Severe COPD (PERSIST COPD-2)
Ages 40 Years to 80 Years · 9 sites · GlaxoSmithKline
Titrated Ambulatory Oxygen in Fibrotic ILD and COPD With Isolated Exertional Hypoxemia
Ages 18 Years to 85 Years · 1 site · State University of New York at Buffalo
Comparing Advanced Technologies to Standard Testing for the Diagnosis of Airway Disease in Hospital and Community Settings
Ages 18 Years to no maximum · 2 sites · University Hospital Southampton NHS Foundation Trust
A Repeat Ascending Dosing Study of the Safety and Clinical Activity of R-3750 in Patients With Mild to Moderate COPD
Ages 40 Years to 82 Years · 0 sites · Rise Therapeutics LLC
Cross-Regional Unmanned Aircraft Transport of Donor Lungs
Ages 18 Years to no maximum · 1 site · The First Affiliated Hospital of Guangzhou Medical University
Evaluation of the Benefits of Hypnosis in Improving the Quality of Life of Patients With Chronic Obstructive Pulmonary Disease (COPD) Suffering From Persistent Dyspnea
Ages 18 Years to no maximum · 1 site · Assistance Publique - Hôpitaux de Paris
ECHO-COPD: Impact of a Pharmacist-Led Health Belief Model-Based Educational Intervention Among Chronic Obstructive Pulmonary Disease Patients
Ages 18 Years to 65 Years · 1 site · Rabia Hussain
New Diagnostic Approaches in the Management of Inflammatory Lung Diseases
Ages 18 Years to no maximum · 0 sites · Fondazione Don Carlo Gnocchi ETS
Creation of a Biological Collection of BRonchiaI and Pulmonary Tissues From Surgical wastE
Ages 1 Year to 80 Years · 1 site · University Hospital, Bordeaux
Factors Associated With Acceptance of Home-Based Pulmonary Telerehabilitation in COPD
Ages 18 Years to no maximum · 1 site · ADIR Association
Dynamic Changes in Right Ventricle and Pulmonary Artery Coupling Among COPD Patients With Acute Exacerbation
Ages 40 Years to no maximum · 1 site · Assiut University
FITME Study: Formulating Individualised Exercise Prescription in Chronic Obstructive Pulmonary Disease
Ages 18 Years to no maximum · 1 site · Aveiro University
HFNC During Bronchoscopy in COPD Patients
Ages 18 Years to no maximum · 0 sites · The First Affiliated Hospital of Guangzhou Medical University
Time Course of Respiratory Oscillometry Parameters During Nasal High-Flow Therapy in Stable Chronic Obstructive Pulmonary Disease
Ages 18 Years to 85 Years · 1 site · ADIR Association
Immuno-inflammatory Response of Erdosteine in COPD
Ages 45 Years to no maximum · 1 site · Pierachille Santus, MD, PhD
Impact of Combined Cardio-pulmonary Assessment on COPD Clinical Management.
Ages 41 Years to no maximum · 0 sites · University of Bari Aldo Moro
EFFECTIVENESS OF COMBINED CONCENTRIC AND ECCENTRIC AEROBIC EXERCISE ON A TREADMILL IN PATIENTS WITH COPD: A RANDOMIZED CLINICAL TRIAL.
Ages 18 Years to no maximum · 1 site · Universidad Europea de Madrid
Extracorporeal Carbon Dioxide Removal Plus Noninvasive Ventilation in Patients With COPD Not Eligible for Intubation
Ages 18 Years to no maximum · 1 site · Hospital del Mar Research Institute (IMIM)
Modulating Locomotor-Respiratory Coupling Through Adaptive Exoskeleton Assistance in Patients With COPD
Ages 45 Years to 75 Years · 1 site · University of Nebraska
Muscle Oxygenation in Patients With COPD Exacerbation
Ages 40 Years to no maximum · 1 site · Hacettepe University
High-Flow Nasal Cannula Oxygenation During Sedated Gastrointestinal Endoscopy in Patients With Chronic Obstructive Pulmonary Disease
Ages 18 Years to no maximum · 1 site · Zhejiang University
The Effect of Pranayama Practiced With Rain Sounds on Self-Efficacy, Dyspnea, and Respiratory Functions in Patients With COPD
Ages 18 Years to no maximum · 0 sites · Inonu University
GLP-1 Agonists for Lung Function Improvement and Muscle Restoration in COPD
Ages 40 Years to 80 Years · 1 site · The Cleveland Clinic
More: Acne clinical trials · Alzheimer’s disease and related dementias clinical trials · Cannabis use disorder clinical trials · Chronic hives (chronic urticaria) clinical trials · Depression clinical trials · Depression (major depressive disorder) clinical trials · Moderately to severely active crohn's disease clinical trials · Osteoporosis clinical trials · Rett syndrome clinical trials